Fed. Circ. Upholds Diazyme Win On Assays Patents

Law360, New York (May 12, 2008, 12:00 AM EDT) -- An appeals court on Monday upheld a lower court's decision that Diazyme Laboratories, the life sciences division of California-based General Atomics, did not infringe Axis-Shield ASA's patents for enzymatic homocysteine tests.

Ian Gilham, Axis-Shield's CEO, said that the company's attorneys were reviewing the decision but that unless they concluded that the court's reasoning was severely flawed, they would probably not appeal it.

“The most likely outcome is that we're going to accept it and move on,” he said.

The conflict centers on the companies’ enzymatic homocysteine...
To view the full article, register now.